Kintara Therapeutics Financials

Kintara Therapeutics Stock Summary

Kintara Therapeutics competes with SAB Biotherapeutics, Theriva Biologics, Lisata Therapeutics, Dyadic International, and Forte Biosciences. Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California. Kintara Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Kintara Therapeutics Key Financial Ratios

Kintara Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kintara Therapeutics's current stock value. Our valuation model uses many indicators to compare Kintara Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kintara Therapeutics competition to find correlations between indicators driving Kintara Therapeutics's intrinsic value. More Info.Kintara Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kintara Therapeutics' earnings, one of the primary drivers of an investment's value.

Kintara Therapeutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Kintara Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kintara Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kintara Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Kintara Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kintara Therapeutics's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.